About Pharmatis
Pharmatis is a company based in Estrees-saint-denis (France) founded in 2001 was acquired by UI Gestion in July 2018. Pharmatis has raised $34.27 million across 1 funding round from investors including Bpifrance, UI Investissement and Africinvest. Pharmatis offers products and services including Unit-dose Packaging and Pharmastick®.
- Headquarter Estrees-saint-denis, France
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pharmatis.fr
- Acquired by UI Gestion (Jul 2018)
- Legal Name Pharmatis
- Total Equity Funding$34.27M (USD)
in 1 rounds
- Latest Funding Round$34.27M (USD), Private Equity Round
Jul 2017
- InvestorsBpifrance
& 3 more
- Acquired byUI Gestion
(Jul 2018)
Products & Services of Pharmatis
Pharmatis offers a comprehensive portfolio of products and services, including Unit-dose Packaging and Pharmastick®.
Packaging for liquids and semi-liquids in sachets and ampoules is handled by Pharmatis for pharmaceutical uses.
Stickpacks for unit-dose applications are created by Pharmatis to support liquid and semi-liquid packaging needs.
Funding Insights of Pharmatis
Pharmatis has successfully raised a total of $34.27M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $34.27 million completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $34.27M
- Total Rounds 1
- Last Round Private Equity Round — $34.27M
- First Round $34.27M
(Jul 2017)
- Investors Count 1
All 1 funding rounds of Pharmatis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2017 | $34.27M | Private Equity Round | – | – |
4 investors in total: 4 institutional.
Investors in Pharmatis
Pharmatis has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, UI Investissement and Africinvest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
UI Investissement is engaged in private equity and investment support for SMEs and mid-sized companies across France. | – | uigestion.com | Paris, France | |
Private equity firm | – | africinvest.com | Paris, France | |
Provides mutual health, property, casualty, and pension insurance services. | 2005 | macsf.fr | La Defense, France | |
Corporate consultancy, advisory, and funding services are provided to businesses. | 2012 | bpifrance.com | Maisons Alfort, France |
Investor details for Pharmatis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Pharmatis
1 people are tracked at Pharmatis (1 in leadership).
| Name | Role | Group |
|---|---|---|
M. Jean-Louis Vouzellaud | CEO | Leadership |
Complete people profiles for Pharmatis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Pharmatis
3 dated milestones of Pharmatis across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Pharmatis is founded.
- Funding First funding round of $34.3M.
- Exit Acquired by UI Gestion.
Similar companies to Pharmatis
10 companies that operate in the same segment as Pharmatis (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pharmatis
Pharmatis was founded in 2001 and raised its 1st funding round 16 years after it was founded.
Pharmatis is headquartered in Estrees-saint-denis, France. It is registered at Estrees-saint-denis, Oise, France.
M. Jean-Louis Vouzellaud is the current CEO of Pharmatis.
Pharmatis is a funded company, having raised a total of $34.27M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $34.27M, raised on Jul 2017.
Founded in 2001, Pharmatis is based in Estrees Saint Denis, France, and operates within the pharmaceutical sector. Generic finished formulations are produced, with specialization in liquids and ointments. Therapeutic categories covered include antibiotics, analgesics, antifungals, dermatological treatments, and additional areas. Operations focus on manufacturing processes tailored to these product types for distribution in relevant markets.
Pharmatis offers Unit-dose Packaging and Pharmastick®.
Pharmatis has 4 investors. Key investors include Bpifrance, UI Investissement, Africinvest, and MACSF.
Pharmatis operates through Pharmatis.
Yes. Pharmatis was acquired by UI Gestion in July 2018.